Lupus Conference in Weeks, New Lupus Drug's Phase II Trial Shows Promise

November 16, 2015

Get $50, Give $25 to Participate in Lupus Study

Bay area residents: Make a difference in 30 minutes!

Help advance research for new lupus treatments by donating a sample of blood from the comfort of your home with Sanguine. When you donate, Sanguine Biosciences will give you $50 for your time and donate $20 to a charity of your choice, like the LFNC.

Click here to sign up or call 818-804-2462.

Make the Lupus Buddy Program Catch Fire

The Lupus Buddy Program - the first of its kind in lupus - is not even a month old (we launched it on July 15), and we already have almost 60 people signed up! Now that's something.

The interest in the program launched by the LFNC working with a volunteer coordinator tells us how valuable patients are finding it - not just in northern California but across the country. And although we couldn't be happier to see it take off among patients, one thing is holding us back from much broader outreach, recruitment and expansion: Funding.

You can solve that problem. Give just $25 (more if you can), then share our funding page with all your friends on your social networks. Donate now.

We started with a small seed funding from GSK, but we need to raise $10,000 more to help lupus patients from sea to shining sea. Why? We need time from program coordinators to match the patients, for orientation, for follow-up, for helping each pair of buddies at every stage. Give now, share and make it catch fire.

If you are a patient interested in the program, learn more, and sign up here. A program coordinator will be in touch with you. Any personal and medical information necessary to make the matches are treated with the highest degree of confidentiality.

LFNC is an active partner in

Information contained in this e-Newsletter should not be considered a substitute for professional diagnosis, treatment or management of S.L.E. and symptoms by a physician.

Missed a previous issue of this e-Newsletter?
You can now view our ARCHIVES.

Editor: Spandan Chakrabarti

You are receiving this newsletter because you have subscribed or have participated in our programs or events. We respect your time and privacy. If you prefer not to continue receiving the newsletter, you can click on the "safe unsubscribe" button below. We hope, however, that you will opt to remain on our newsletter list for important information and life-saving tips that you or someone you know may benefit from now or in the future.

Lupus Mini-Conference with Credit for Nurses Coming to Stockton

LFNC's Fall 2015 Lupus Mini-Conference will be headlined by Dr. C. Michael Neuwelt, and held from 11 am to 4 pm on December 5, 2015 at the St. Joseph's Medical Center in Stockton, CA. Our conferences are designed to benefit patients, friends and family and medical professionals alike, and are certified by the California Nursing Board to grant CEU credits to attending California RNs. Please read the agenda here.

Registration fees: $50 for credit attendees, $30 for others. No one will be turned away for inability to pay. Current LFNC members receive a discount of $10 on either registration. Registration is required.

You may register online on our website, or download a registration form mail or fax it to us. Please call us at (408) 954-8600 to register by phone or if you need a fee waiver.

New Lupus Drug's Phase II Trial Shows Promise

In 2011, the FDA approved the first lupus drug in 50 years - Benlysta. While no lupus drug has been approved since, it sparked new effort in the research and pharmaceutical communities to address lupus. Now, a Phase II trial of a new drug called anifrolumab is showing promise.

In findings presented at the 2015 annual meeting of the American College of Rheumatology in San Francisco, California on Nov. 6 to 11, the drug shows promising effectiveness against moderate to severe SLE. The drug was also shown to reduce the need for corticosteroids in patients in the trial. Corticosteroids such as prednisone are commonly used to treat lupus, but their long term side effects limit their effectiveness.

LFNC's national research partners at the Lupus Research Institute have released a statement congratulating AstraZeneca, the maker of the drug on its advancement. We join the LRI in expressing our optimism as well.

Read more about the trial here. The Phase III of the trial is currently under way.

They'll be gone soon!

One great cause. One beauty of a sedan.

Less than 200 left, out of a total of 600. Get yours now!

Win a Mercedes CLA-250, or $25,000 in cash.

Want it? Get in fast before all 600 tickets sell out!

Tickets: $75 per entry. $200 for three (3) or $300 for five (5)

Call us at (408) 954-8600 for the fastest way to buy your tickets or complete this form and mail or fax it to us. Remember, the more tickets you buy, the better your chances!

When is the giveaway?

As soon as the 600th ticket is sold!